Low-intensity extracorporeal shock wave therapy (Li-ESWT) for priapism-induced erectile dysfunction in young patients: the first case series-Reference-Cited by-同舟云学术

Low-intensity extracorporeal shock wave therapy (Li-ESWT) for priapism-induced erectile dysfunction in young patients: the first case series

Published:2021-04-05 Issue: Volume: Page:
ISSN:0955-9930
Container-title:International Journal of Impotence Research
language:en
Short-container-title:Int J Impot Res

Author:

Cocci Andrea^ORCID,Fassio Giulia,Migliorini Filippo,Cito Gianmartin^ORCID,Antonelli Alessandro^ORCID,Verrienti Pierangelo^ORCID,Scandura Carmen,Tuccio Agostino,Minervini Andrea,Masieri Lorenzo,Tafuri Alessandro

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://www.nature.com/articles/s41443-021-00429-4.pdf

Reference5 articles.

1. Kanika N, Melman A, Davies K. Experimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue. Int J Impot Res. 2010;22:363–73. https://doi.org/10.1038/ijir.2010.27.

2. Hoffman S, Kaynan A, Melman A. Priapism of ambiguous classification in a sickle cell patient. Int J Impot Res. 2000;12:59–63. https://doi.org/10.1038/sj.ijir.3900459.

3. Vardi Y, Appel B, Kilchevsky A, Gruenwald I. Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study. J Urol 2012;187:1769–75. https://doi.org/10.1016/j.juro.2011.12.117. Epub 2012 Mar 15. PMID: 22425129

4. Di Mauro M, Russo GI, Della Camera PA, Di Maida F, Cito G, Mondaini N, et al. Extracorporeal shock wave therapy in peyronie’s disease: clinical efficacy and safety from a single-arm observational study. World J Mens Health. 2019;37:339–46. https://doi.org/10.5534/wjmh.180100. Epub 2019 Mar 26. PMID: 30929330; PMCID: PMC6704308

5. Palmieri A, Arcaniolo D, Palumbo F, Verze P, Liguori G, Mondaini N, et al. Low intensity shockwave therapy in combination with phosphodiesterase-5 inhibitors is an effective and safe treatment option in patients with vasculogenic ED who are PDE5i non-responders: a multicenter single-arm clinical trial. Int J Impot Res. 2020. https://doi.org/10.1038/s41443-020-0332-7.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-intensity extracorporeal shock wave therapy for erectile dysfunction: Myths and realities;Investigative and Clinical Urology;2023